{
  "ptid_time": "068_S_4859_2012-08-03",
  "img_path": "/data/qiuhui/data/adni/images/068_S_4859/2012-08-03/t1.nii.gz",
  "img_finding": "Image findings: ventricular volume measures 125,840 mm³, 226.7% above the reference mean. With a Z-score of 5.43 (100.0th percentile), this represents profound enlargement; hippocampal volume measures 6,769 mm³, 10.5% below the reference mean. With a Z-score of -1.02 (15.4th percentile), this represents mild atrophy; whole brain volume measures 1,166,710 mm³, 8.1% above the reference mean. With a Z-score of 1.05 (85.3th percentile), this represents mild enlargement. ",
  "text_data": "Age is 72.2 years. Gender is Male. Education: 20 years. Handedness: Right. Race: White. Medical history: Psychiatric; Neurologic; Cardiovascular; Endocrine-Metabolic; Renal-Genitourinary; Major Surgical Procedures. MMSE: 24.0. MoCA: 22.0. Logical Memory: 1.0. APOEε4 alleles: 1.0. Biomarker levels: Florbetapir (AV45): 1.79 SUVR (profound elevated); Amyloid beta: 514.60 pg/mL (mild reduced); Total tau: 247.40 pg/mL (normal ); Phosphorylated tau: 25.23 pg/mL (normal ). ",
  "true_diagnosis": "Diagnosis: AD.",
  "gpt_diagnosis": "**Reasoning:** The data shows profound ventricular enlargement (Z-score 5.43) and mild hippocampal atrophy (Z-score -1.02), along with mildly reduced Aβ and profoundly elevated AV45 (indicating amyloid deposition). The MMSE (24) and MoCA (22) scores suggest mild cognitive impairment, while normal T-tau and P-tau levels argue against advanced neurodegeneration.  \n\n**Diagnosis:** **Mild Cognitive Impairment (MCI)** (likely amyloid-positive, early neurodegenerative changes)  \n**Confidence:** **Medium** (clear structural and biomarker abnormalities, but cognitive scores are borderline and tau levels are normal)",
  "timestamp": "2025-07-26T09:03:13.078040"
}